Jayne S. Sutherland

ORCID: 0000-0002-7083-4997
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Pneumonia and Respiratory Infections
  • Infectious Diseases and Tuberculosis
  • vaccines and immunoinformatics approaches
  • Immunodeficiency and Autoimmune Disorders
  • Diagnosis and treatment of tuberculosis
  • T-cell and B-cell Immunology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Immunotherapy and Immune Responses
  • Influenza Virus Research Studies
  • Immune responses and vaccinations
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • Respiratory viral infections research
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • HIV Research and Treatment
  • Hematological disorders and diagnostics
  • Biochemical and Molecular Research
  • COVID-19 Clinical Research Studies
  • S100 Proteins and Annexins
  • Immune cells in cancer
  • Iron Metabolism and Disorders
  • Complement system in diseases
  • Vaccine Coverage and Hesitancy

MRC Unit the Gambia
2016-2025

Başkent University Hospital
2023

Universitat de Barcelona
2023

Barcelona Institute for Global Health
2023

European Respiratory Society
2023

Swansea Bay University Health Board
2020

Morriston Hospital
2020

Medical Research Council
2012-2019

London School of Hygiene & Tropical Medicine
2019

New York University
2013

Abstract The thymus undergoes age-related atrophy, coincident with increased circulating sex steroids from puberty. impact of thymic atrophy is most profound in clinical conditions that cause a severe loss peripheral T cells the ability to regenerate adequate numbers naive CD4+ indirectly correlating patient age. present study demonstrates androgen ablation results complete regeneration aged male mouse thymus, restoration cell phenotype and function enhanced following bone marrow...

10.4049/jimmunol.175.4.2741 article EN The Journal of Immunology 2005-08-15
Sara Suliman Ethan Thompson Jayne S. Sutherland January Weiner Martin O. C. Ota and 95 more Steven G. Smith Adam Penn‐Nicholson Bonnie Thiel Mzwandile Erasmus Jeroen Maertzdorf Fergal J. Duffy Philip C. Hill E. Jane Hughes Kim Stanley Katrina Downing Michelle Fisher Joe Valvo Shreemanta K. Parida Gian van der Spuy Gerard Tromp Ifedayo Adetifa Simon Donkor Rawleigh Howe Harriet Mayanja‐Kizza W. Henry Boom Hazel M. Dockrell Tom H. M. Ottenhoff Mark Hatherill Alan Aderem Willem A. Hanekom Thomas J. Scriba Stefan H. E. Kaufmann Daniel E. Zak Gerhard Walzl Gerhard Walzl Gillian F. Black Gian van der Spuy Kim Stanley Magdalena Kriel Nelita du Plessis Nonhlanhla Nene Teri Roberts Léanie Kleynhans Andrea Gutschmidt Bronwyn Smith Nonhlanhla Nene André G. Loxton Novel N. Chegou Gerard Tromp David L. Tabb Tom H. M. Ottenhoff Michèl R. Klein Mariëlle C. Haks Kees L. M. C. Franken Annemieke Geluk Krista E. van Meijgaarden Simone A. Joosten W. Henry Boom Bonnie Thiel Harriet Mayanja‐Kizza Moses Joloba Sarah Zalwango Mary Nsereko Brenda Okwera Hussein Kisingo Stefan H. E. Kaufmann Shreemanta K. Parida Robert Golinski Jeroen Maertzdorf January Weiner Mark Z. Jacobson Hazel M. Dockrell Steven G. Smith Patricia Gorak‐Stolinska Yun‐Gyoung Hur Maeve K. Lalor Ji‐Sook Lee Amelia C. Crampin Neil French Bagrey Ngwira Anne Ben‐Smith Kate E. Watkins Lyn Ambrose Felanji Simukonda Hazzie Mvula Femia Chilongo Jacky Saul Keith Branson Sara Suliman Thomas J. Scriba Hassan Mahomed E. Jane Hughes Nicole Bilek Mzwandile Erasmus Onke Xasa Ashley Veldsman Katrina Downing Michelle Fisher Adam Penn‐Nicholson Humphrey Mulenga

Rationale: Contacts of patients with tuberculosis (TB) constitute an important target population for preventive measures because they are at high risk infection Mycobacterium and progression to disease.Objectives: We investigated biosignatures predictive ability incident TB.Methods: In a case–control study nested within the Grand Challenges 6-74 longitudinal HIV-negative African cohort exposed household contacts, we employed RNA sequencing, PCR, pair ratio algorithm in training/test set...

10.1164/rccm.201711-2340oc article EN American Journal of Respiratory and Critical Care Medicine 2018-04-06

Abstract Age-associated thymic involution is accompanied by decreased output. This adversely affects general immune competence and T cell recovery following cytoreductive treatments such as chemotherapy. A causal link between increasing sex steroids age-related atrophy well established. Although castration has been demonstrated to regenerate the atrophied thymus, little known about how this initiated or kinetics of thymocyte regeneration. The present study shows that although impacts...

10.4049/jimmunol.175.5.2982 article EN The Journal of Immunology 2005-09-01

Tuberculosis (TB) remains a global health problem. The solution involves development of an effective vaccine, but has been limited by incomplete understanding what constitutes protective immunity during natural infection with Mycobacterium tuberculosis. In this study, M. tuberculosis-specific responses following overnight whole-blood assay were assessed intracellular cytokine staining and luminex, compared between TB cases exposed household contacts. had significantly higher levels...

10.1002/eji.200838693 article EN European Journal of Immunology 2009-02-17

<h3>Background</h3> User-friendly, rapid, inexpensive yet accurate TB diagnostic tools are urgently needed at points of care in resource-limited settings. We investigated host biomarkers detected serum samples obtained from adults with signs and symptoms suggestive primary healthcare clinics five African countries (Malawi, Namibia, South Africa, The Gambia Uganda), for the diagnosis disease. <h3>Methods</h3> prospectively enrolled individuals presenting warranting investigation pulmonary TB,...

10.1136/thoraxjnl-2015-207999 article EN Thorax 2016-05-04
January Weiner Jeroen Maertzdorf Jayne S. Sutherland Fergal J. Duffy Ethan Thompson and 95 more Sara Suliman Gayle K. McEwen Bonnie Thiel Shreemanta K. Parida Joanna Żyła Willem A. Hanekom Robert P. Mohney W. Henry Boom Harriet Mayanja‐Kizza Rawleigh Howe Hazel M. Dockrell Tom H. M. Ottenhoff Thomas J. Scriba Daniel E. Zak Gerhard Walzl Stefan H. E. Kaufmann Almaz Abebe Bernd Abel Richard A. Adegbola Ifedayo Adetifa Lyn Ambrose Peter Andersen Martín Antonio Abraham Aseffa Debbie van Baarle Lew Barker Yonas Bekele Nicole Bilek Gillian F. Black Mark Bowmaker Keith Branson Michael J. Brennan Novel N. Chegou Femia Chilongo William Kwong Chung Tumani Corrah Ameilia C. Crampin Mark Doherty Gregory Dolganov Simon Donkor Katrina Downing Michelle Fisher Kees L. M. C. Franken Neil French Larry Geiter Annemieke Geluk Robert Golinski Patricia Gorak‐Stolinska Mariëlle C. Haks Philip C. Hill Jane Hughes Yun‐Gyoung Hur Rachel Iwnetu Mark Z. Jacobson Moses Joloba Simone A. Joosten Benjamin M. Kagina Desta Kassa Hussein Kisingo Michèl R. Klein Magdalena Kriel Maeve K. Lalor Ji‐Sook Lee André G. Loxton Hassan Mahomed Krista E. van Meijgaarden Tsehayenesh Mesele Frank Miedema Adane Mihret Humphrey Mulenga Stefanie Müller Hazzie Mvula Nonhlanhla Nene Bagrey Ngwira Mary Nsereko Brenda Okwera Martin O. C. Ota Adam Penn‐Nicholson Nelita du Plessis Srinivasan Ramachandran Ida Rosenkrands Jerry Sadoff Jacky Saul Gary K. Schoolnik Felanji Simukonda Donata Sizemore Steven G. Smith Anne Ben Smith Gian van der Spuy Kim Stanley David L. Tabb Mesfin Tafesse Belete Tegbaru Toyin Togun Gerard Tromp

New biomarkers of tuberculosis (TB) risk and disease are critical for the urgently needed control ongoing TB pandemic. In a prospective multisite study across Subsaharan Africa, we analyzed metabolic profiles in serum plasma from HIV-negative, TB-exposed individuals who either progressed to 3-24 months post-exposure (progressors) or remained healthy (controls). We generated trans-African biosignature TB, which identifies future progressors both on blinded test samples external data sets...

10.1038/s41467-018-07635-7 article EN cc-by Nature Communications 2018-11-30
Adam Penn‐Nicholson Stanley Kimbung Mbandi Ethan Thompson Simon C. Mendelsohn Sara Suliman and 95 more Novel N. Chegou Stephanus T. Malherbe Fatoumatta Darboe Mzwandile Erasmus Willem A. Hanekom Nicole Bilek Michelle Fisher Stefan H. E. Kaufmann Jill Winter Melissa Murphy Robin Wood Carl Morrow Ildiko Van Rhijn Branch Moody Megan Murray Bruno B. Andrade Timothy R. Sterling Jayne S. Sutherland Kogieleum Naidoo Nesri Padayatchi Gerhard Walzl Mark Hatherill Daniel E. Zak Thomas J. Scriba Fazlin Kafaar Leslie Workman Humphrey Mulenga E. Jane Hughes Onke Xasa Ashley Veldsman Yolundi Cloete Deborah Abrahams Sizulu Moyo Sebastian Gelderbloem Michèle Tameris Hennie Geldenhuys Rodney Ehrlich Suzanne Verver Larry Geiter Gillian F. Black Gian van der Spuy Kim Stanley Magdalena Kriel Nelita du Plessis Nonhlanhla Nene Teri Roberts Léanie Kleynhans Andrea Gutschmidt Bronwyn Smith André G. Loxton Gerard Tromp David L. Tabb Tom H. M. Ottenhoff Michèl R. Klein Mariëlle C. Haks Kees L. M. C. Franken Annemieke Geluk Krista E. van Meijgaarden Simone A. Joosten W. Henry Boom Bonnie Thiel Harriet Mayanja‐Kizza Moses Joloba Sarah Zalwango Mary Nsereko Brenda Okwera Hussein Kisingo Shreemanta K. Parida Robert Golinski Jeroen Maertzdorf January Weiner Mark Z. Jacobson Hazel M. Dockrell Steven G. Smith Patricia Gorak‐Stolinska Yun‐Gyoung Hur Maeve K. Lalor Ji‐Sook Lee Amelia C. Crampin Neil French Bagrey Ngwira Anne Ben‐Smith Kate E. Watkins Lyn Ambrose Felanji Simukonda Hazzie Mvula Femia Chilongo Jacky Saul Keith Branson Hassan Mahomed E. Jane Hughes Onke Xasa Ashley Veldsman Katrina Downing Humphrey Mulenga

Abstract Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently needed. We developed a robust simple, PCR-based host-blood transcriptomic signature, RISK6, multiple applications: identifying individuals at risk of incident disease, as screening test subclinical or clinical tuberculosis, treatment. RISK6 utility was validated by blind prediction using quantitative real-time (qRT) PCR in seven independent cohorts. Prognostic performance significantly...

10.1038/s41598-020-65043-8 article EN cc-by Scientific Reports 2020-05-25

Background A nonsputum blood test capable of predicting progression healthy individuals to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment curb transmission. We aimed develop a proteomic biomarker risk TB for ultimate translation into point-of-care diagnostic. Methods and findings Proteomic signatures were discovered in longitudinal cohort 6,363 Mycobacterium tuberculosis-infected, HIV-negative South African adolescents aged 12–18 years (68% female)...

10.1371/journal.pmed.1002781 article EN cc-by PLoS Medicine 2019-04-16

The development of a fast and accurate, non-sputum-based point-of-care triage test for tuberculosis (TB) would have major impact on combating the TB burden worldwide. A new fingerstick blood has been developed by Cepheid (the Xpert MTB Host Response [MTB-HR] prototype), which generates "TB score" based messenger RNA (mRNA) expression 3 genes. Here we describe first prospective findings MTB-HR prototype.

10.1093/cid/ciab839 article EN cc-by Clinical Infectious Diseases 2021-09-17

The experiences of frontline healthcare professionals are essential in identifying strategies to mitigate the disruption services caused by COVID-19 pandemic.We conducted a cross-sectional study TB and HIV low middle-income countries (LMIC). Between May 12 August 6, 2020, we collected qualitative quantitative data using an online survey 11 languages. We used descriptive statistics thematic analysis analyse responses.669 respondents from 64 completed survey. Over 40% stated that it was either...

10.1371/journal.pone.0244936 article EN cc-by PLoS ONE 2021-02-02

To determine if temporarily blocking sex steroids prior to stem cell transplantation can increase thymus function and thus enhance the rate of T regeneration.This was a pilot study luteinizing hormone-releasing hormone agonist (LHRH-A) goserelin given 3 weeks allogeneic or autologous hemopoietic administered up months posttransplantation. Patients (with without LHRH-A administration) were assessed from 1 week 12 posttransplantation for multiple immunologic variables by flow cytometry...

10.1158/1078-0432.ccr-07-1784 article EN Clinical Cancer Research 2008-02-15

Background Mycobacterium tuberculosis (MTb) infects approximately 2 billion people world-wide resulting in almost million deaths per year. Determining biomarkers that distinguish different stages of (TB) infection and disease will provide tools for more effective diagnosis ultimately aid the development new vaccine candidates. The current diagnostic kits utilising production IFN-γ response to TB antigens can detect MTb but are unable between disease. aim this study was assess if use a longer...

10.1371/journal.pone.0012365 article EN cc-by PLoS ONE 2010-08-24

Background. Anemia is common in tuberculosis, and multiple etiologies necessitate targeted interventions. The proportion of iron-responsive anemia due to iron deficiency compared with iron-unresponsive impaired absorption/redistribution from tuberculosis-associated immune activation or inflammation unknown. This impedes selection safe effective treatment appropriate intervention timing. Methods. Baseline hemoglobin, ferritin, hepcidin, soluble transferrin receptor (sTfR), were measured 45...

10.1093/cid/ciu945 article EN Clinical Infectious Diseases 2014-11-26

ABSTRACT The Mycobacterium tuberculosis genome includes the large family of pe_pgrs genes, whose functions are unknown. Because precedents in other pathogens which gene families showing high sequence variation involved antigenic variation, a similar role has been proposed for genes. However, impact immune selection on genes not examined. Here, we sequenced 27 94 clinical strains from five phylogenetic lineages M. complex (MTBC). We found that were overall more diverse than remainder MTBC...

10.1128/mbio.00960-13 article EN cc-by-nc-sa mBio 2014-01-15

IL-17 producing cells have been shown to be important in the early stages of Mycobacterium tuberculosis (Mtb) infection animal models. However, there is very little data on role human studies TB. We recruited TB patients and their highly exposed contacts who were further categorised based results from an IFN-γ release assay (IGRA): 1) IGRA+ at recruitment (latently infected (LTBI)), 2) IGRA negative 6 months (non-converters (NC)) 3) positive (converters (C)). Whole blood was stimulated with...

10.3389/fimmu.2017.01252 article EN cc-by Frontiers in Immunology 2017-10-11

Background: Tuberculosis (TB) remains a major threat to global health. Currently, diagnosis of active TB is hampered by the lack specific biomarkers that discriminate disease from other (lung) diseases or latent infection (LTBI). Integrated human gene expression results have shown genes encoding complement components, in particular different C1q chains, were expressed at higher levels compared LTBI. Methods: protein determined using ELISA sera patients, geographically distinct populations,...

10.3389/fimmu.2018.02427 article EN cc-by Frontiers in Immunology 2018-10-23

Up to fifty percent of microbiologically cured tuberculosis (TB) patients may be left with permanent, moderate or severe pulmonary function impairment. Very few studies have systematically examined outcomes in understand the pathophysiologic basis and long-term socio-economic consequences this injury. The planned multi-country, multi-centre observational TB cohort study, aims advance understanding clinical, microbiological, immunological risk factors affecting outcome TB. It will also...

10.1186/s12890-018-0777-3 article EN cc-by BMC Pulmonary Medicine 2019-01-07
Coming Soon ...